Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …

Metabolic‐associated steatotic liver disease (MASLD) encompasses a wide spectrum of
metabolic conditions associated with an excess of fat accumulation in the liver, ranging from …

Background Mouse models of alcohol‐associated liver disease vary greatly in their ease of
implementation and the pathology they produce. Effects range from steatosis and mild …

Background Alcohol misuse, binge drinking pattern, and gender-specific effects in the
middle-aged population has been clearly underestimated. In the present study, we focused …

Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) have emerged
as leading causes of chronic liver diseases worldwide. ALD and NAFLD share several …

Abstract Background & Aim Expression of P21, encoded by the CDKN1A gene, has been
associated with fibrosis progression in steatotic liver disease (SLD); however, the underlying …

Abstract Background and Aims Extracellular vesicles (EVs) have emerged as a potential
source of circulating biomarkers in liver disease. We evaluated circulating AV+ EpCAM+ …

This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain,
in October 2021. The meeting, which was organized by the Spanish Association for the …

Background: The recent increase in the incidence of alcohol-associated hepatitis (AH)
coincides with the obesity epidemic in the United States. However, current mouse models do …

Hepatology AASLD Publications Hepatology Liver Transplantation Clinical Liver Disease
Hepatology Communications Log in or Register Subscribe to journalSubscribe Get new issue …